Authors



Jordan Miller, MD

Latest:

Jordan Miller, MD: 2024 Dermatology Predictions

Advancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.


Pahroul Davé, APN

Latest:

The Dx and Rx of Congenital Malalignment Syndrome in Children

Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.


Pearl Grimes, MD, FAAD

Latest:

Redefining Vitiligo Management: FDA-Approved Topical Ruxolitinib and the Evolving Treatment Paradigm

Pearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and its impact on management strategies.


Maggie L. Shaw

Latest:

Eczema Prevalence Varies by Race and Ethnicity, With Overall Increase Seen

Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.



Jill Waibel, MD

Latest:

Jill Waibel, MD, FAAD: Innovations in Laser Modalities for the Treatment of Scars

Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.


Laura Joszt, MA

Latest:

Drug Survival of Biosimilars, Originator TNF Inhibitors Similar

The rates of discontinuation due to inefficacy or adverse events for biosimilars and originators of etanercept and adalimumab were similar, according to an analysis of a prospective registry.


Girish Gupta, MB ChB, FRCP

Latest:

85% of Survey Respondents Do Not Know What Actinic Keratosis Is

The survey conducted by Almirall included participants in the US and Europe.


Patty Weasler

Latest:

Pulsed Dye Lasers for Cosmetic Procedures

Pulsed dye lasers are now being used for several different dermatologic conditions.


Andrew Mastro, MS, PA-C

Latest:

Updating Treatment Guidelines: Incorporating Novel Therapies to Address Unmet Needs

Psoriasis specialists evaluate strategies for integrating emerging therapies into existing treatment protocols and conclude by addressing persistent gaps in current psoriasis management approaches.


Omar A. Ibrahimi, MD, PhD

Latest:

New Tech for Skin

There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.


Alex Biese

Latest:

Rare Immune Cell May Predict Immunotherapy Response in Melanoma

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.


Bernard A. Cohen, MD

Latest:

A Novel Approach to Distinguishing Scabies From Atopic Dermatitis

The WHO underscores the significance of addressing scabies as a neglected skin disease, especially in regions with limited health care access.


Matt Leavitt, DO

Latest:

Addressing Causes of Female Hair Loss and Exploring Preventative Measures

This expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.


Nicholas Brownstone, MD

Latest:

Comparing Devices to Assess Facial Pigmentary and Inflammatory Conditions

Precision measurements are necessary to improve the current therapeutic armamentarium in pigmentary disorders.



Katherine Economy, MD

Latest:

Navigating Pregnancy, Dermatology, and Drug Safety

Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.


Brad Glick, DO, MPH, FAOCD

Latest:

Challenges and Successes in Photodynamic Therapy

Brad Glick, DO, MPH, discusses common challenges clinicians may encounter with photodynamic therapy (PDT) and offers resolution strategies, while also sharing insights on the skin conditions and patient populations where PDT has proven to be a successful treatment option.


Lauren Miller, PA-C

Latest:

Lauren Miller, PA-C, Highlights the Value of Collaboration With APPs and More

Miller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.


Monica Harilall, PA-C, MMS

Latest:

Case 2: Male, 20 Years Old

An expert in the management of skin conditions provides an overview of a 20-year-old male diagnosed with atopic dermatitis, discussing key insights from a round table discussion. The conversation focused on effective management strategies, best practices for prior authorization approvals, and the significance of treatment vehicles.


Andrew Weinstein, MD, FAAD

Latest:

Expert Perspectives on BOLT clinical trial data

John Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.


Lauren Massaro

Latest:

The Role of Pharmacists in Skin Care Education in the Age of Social Media

Social media is fraught with misinformation. Pharmacists play a key role in breaking through the fallacies with facts and education on skin care.


Lindsey Carr, Editor

Latest:

Clinical Considerations for Monkeypox in Pregnancy

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.




Marta Calbet, PhD

Latest:

Expert Insights Into the Relationship Between the Hippo Pathway and Extensive Fibrosis in HS

Researchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.


TJ Chao, MPAS, PA-C

Latest:

Updating Treatment Guidelines: Incorporating Novel Therapies to Address Unmet Needs

Psoriasis specialists evaluate strategies for integrating emerging therapies into existing treatment protocols and conclude by addressing persistent gaps in current psoriasis management approaches.


Jennifer Barrett

Latest:

FDA approves topical for actinic keratosis

Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.


Nick Loftin

Latest:

5 steps to make telehealth work for physicians and patients

There are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.

© 2024 MJH Life Sciences

All rights reserved.